Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

A new gene, JMJD1C, may affect testosterone levels in men.

Testosterone may slow down wound healing and increase inflammation.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Acne is an important sign of androgen excess disorders in women.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Dutasteride and finasteride affect different cell types differently.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

PRP improves hair thickness for both genders, but only increases hair density in men.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

New steroids were effective in blocking male hormone receptors in hamster prostates.

PRP treatment significantly increased hair density and thickness in male hair loss.